News

A brain-computer interface (BCI) surgically implanted on the brain of an ALS (amyotrophic lateral sclerosis) patient has shown success in translating brain signals into computer commands.

The model's results correlated 85% with those calculated by a musculoskeletal pathologist.

Phillip, an assistant professor in the Department of Biomedical Engineering, has received a Junior Faculty award from the American Federation for Aging Research—Glenn Foundation to identify and classify subtypes of senescent cells.

The BRAIN CONNECTS program supports 11 projects that aim to develop technologies to comprehensively map neural connections in both humans and laboratory animals.

Funding from the Advanced Research Projects Agency for Health (ARPA-H) will fast-track the development of new cancer implant technology.

Breakthrough research from Jamie Spangler, an assistant professor of chemical and biomolecular engineering and biomedical engineering, has potential implications for treatment of injuries.

Deep-learning technology developed by Johns Hopkins researchers could help scientists overcome a major hurdle to developing personalized immunotherapies and vaccines.

New machine learning model could enable the development of therapies for cancer or other genomic diseases by activating genes on demand.

For a team of Johns Hopkins scientists, the acceleration of aging in space provides a unique opportunity to better comprehend the condition that remains the leading cause of death in America: heart disease.

Scientists have developed a tool called Geno-DT to create a digital replica of an individual's heart, which could inform the diagnosis and treatment of cardiovascular diseases.

A Johns Hopkins Medicine team suggests that microparticle-delivered therapy may be the first step toward stopping MS and other autoimmune diseases.

Researchers' work may help to predict and prevent the immune response that leads to fibrosis.

Tests in mice with melanoma and colon cancer show tiny particle creates an “army” of immune cells that carry vaccine’s instructions, researchers say.

The Leducq-funded project aims to find new therapies for heart disease by studying the effects of stimulating nerves.

Visualizing connections between nerve cells in the brain could yield insights into how our brains change with learning, aging, injury, and disease.

Dopamine, a brain chemical long associated with pleasure, motivation and reward-seeking, also appears to play an important role in why exercise and other physical efforts feel “easy” to some people and exhausting to others, according to results of a study of people with Parkinson’s disease led by Johns Hopkins Medicine researchers.

Researchers have completed the most advanced brain map to date, that of an insect, a landmark achievement in neuroscience that brings scientists closer to true understanding of the mechanism of thought.

Johns Hopkins Medicine researchers are collaborating with NASA to send human heart “tissue-on-a-chip” specimens into space as early as March. The project is designed to monitor the tissue for changes in heart muscle cells’ mitochondria (their power supply) and ability to contract in low-gravity conditions.

From Alexa to a robot running amok in the movie 'M3GAN', artificial intelligence is part of everyday life and is capturing our imagination. Johns Hopkins AI expert Rama Chellappa helps us sort out fact from fiction, and whether we should embrace the 'AI spring'.

Researchers from Johns Hopkins have created and preliminarily tested what they believe may be one of the first models for predicting who has the highest probability of being resistant to COVID-19 in spite of exposure to SARS-CoV-2, the virus that causes it.

There is a certain class of pediatric brain cancers that is “universally deadly,” with a median survival of 15 months and few, if any, viable treatment options. The key to combating these cancers might be in analyzing how the cells within tumor tissue—cancer cells, immune cells, and others—express genes and organize themselves spatially.

An intensivist at Johns Hopkins Medicine, in collaboration with Johns Hopkins University engineering students, report they have developed artificial intelligence (AI) algorithms that can detect the early warning signs of delirium and can predict — at any time during an ICU stay — a high risk of delirium for a significant number of patients.

Johns Hopkins Medicine researchers say they found that old mice were less capable than young mice of “turning off” certain actively firing brain cells in the midst of ambient noise.

Scientists at Johns Hopkins Medicine say they have developed a computer model — dubbed quantitative fate mapping — that looks back in the developmental timeline to trace the origin of cells in a fully grown organism.

Two new models could solve a problem that’s long frustrated millions of people with epilepsy and the doctors who treat them: how to find precisely where seizures originate to treat exactly that part of the brain.

Johns Hopkins computational biologist Steven Salzberg says controversial Boston University study that created a potentially deadly form of the omicron coronavirus variant should never have happened.

Researchers design a protein that can activate and increase the number of specialized cells that can prevent the onset of autoimmune disorders.

Researchers from Johns Hopkins Medicine have discovered that the organization of different types of immune cells within pancreatic tumors is associated with how well patients with pancreatic cancer respond to treatment and how long they survive.